Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | NSD2 | O96028 | 1/20 | 0.43 |
| ▸ | EGFR | P00533 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 3/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.38 |
| ▸ | NEK2 | P51955 | 1/20 | 0.38 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.38 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.38 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.38 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | HTR1A | P08908 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4719924 | 0.82 | TP53 (0.33) | MAPTALDH1A1LMNAL3MBTL1NSD2 | |
| SCHEMBL217540 | 0.81 | CHEK1 (0.36) | MAPTALDH1A1LMNAL3MBTL1NSD2 | |
| SCHEMBL4722979 | 0.79 | MEN1 (0.36) | MAPTALDH1A1L3MBTL1GAATP53 | |
| SCHEMBL4721790 | 0.79 | DRD3 (0.35) | MAPTALDH1A1LMNAL3MBTL1NSD2 | |
| SCHEMBL15400228 | 0.77 | KDM4E (0.32) | MAPTALDH1A1L3MBTL1TDP1KDM4E | |
| SCHEMBL4765912 | 0.77 | CRHR1 (0.40) | MAPTLMNATP53TSHRHTR1A | |
| SCHEMBL4723422 | 0.77 | KDM4E (0.40) | MAPTALDH1A1LMNATDP1KDM4E | |
| SCHEMBL7520089 | 0.76 | MAPT (0.52) | MAPTALDH1A1LMNAL3MBTL1NSD2 | |
| SCHEMBL9412835 | 0.75 | ALDH1A1 (0.33) | MAPTALDH1A1LMNAL3MBTL1NSD2 | |
| SCHEMBL4723530 | 0.74 | CRHR1 (0.35) | MAPTLMNAGAAKDM4ETP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103946245-B | Catalyst for olefin polymerization and copolymerization and method for olefin polymerization or copolymerization using the same | 韩华道达尔有限公司 | 2018-02-27 | — | — | CN | disclosed |
| EP-1964860-B1 | ETHYLENE POLYMER, CATALYST FOR PRODUCTION OF ETHYLENE POLYMER, AND PROCESS FOR PRODUCTION OF ETHYLENE POLYMER | TOSOH CORP (JP) | 2017-07-05 | — | — | EP | disclosed |
| US-20170114199-A1 | CATALYST FOR OLEFIN POLYMERIZATION AND CO-POLYMERIZATION AND METHOD FOR OLEFIN POLYMERIZATION AND CO-POLYMERIZATION WITH USING THE SAME | HANWHA TOTAL PETROCHEMICAL CO., LTD. | 2017-04-27 | — | — | US | disclosed |
| CN-105820280-A | Ethylene-olefin copolymer and preparation thereof | 韩华道达尔有限公司 | 2016-08-03 | — | — | CN | disclosed |
| EP-1473323-B1 | Polyethylene composition and process for producing same | TOSOH CORP (JP) | 2016-04-27 | — | — | EP | disclosed |
| US-8957159-B2 | Multiple catalyst system for olefin polymerization and polymers produced therefrom | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2015-02-17 | — | — | US | disclosed |
| CN-103946245-A | Catalyst for olefin polymerization and copolymerization and method for olefin polymerization or copolymerization using the same | SAMSUNG TOTAL PETROCHEMICALS | 2014-07-23 | — | — | CN | disclosed |
| US-20140066567-A1 | Multiple Catalyst System for Olefin Polymerization and Polymers Produced Therefrom | EXXONMOBIL CHEMICAL PATENTS INC. | 2014-03-06 | — | — | US | disclosed |
| US-8563647-B2 | Multiple catalyst system for olefin polymerization and polymers produced therefrom | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2013-10-22 | — | — | US | disclosed |
| EP-1620479-B1 | POLYOLEFIN ADHESIVE COMPOSITIONS AND ARTICLES MADE THEREFROM | EXXONMOBIL CHEM PATENTS INC (US) | 2013-07-24 | — | — | EP | disclosed |
| US-20080176857-A1 | 4-Piperazinnylthieno[2,3-d]Pyrimidine Compounds as Platelet Aggregation Inhibitors | PFIZER INC. | 2008-07-24 | — | — | US | disclosed |
| EP-1874780-A1 | 4-PIPERAZINYLTHIENO[2,3-D]PYRIMIDINE COMPOUNDS AS PLATELET AGGREGATION INHIBITORS | Pharmacia & Upjohn Company LLC (US) | 2008-01-09 | — | — | EP | disclosed |
| US-20070293640-A1 | Multiple catalyst system for olefin polymerization and polymers produced therefrom | EXXONMOBIL CHEMICAL PATENTS INC. | 2007-12-20 | — | — | US | disclosed |
| US-7294681-B2 | Mutliple catalyst system for olefin polymerization and polymers produced therefrom | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2007-11-13 | — | — | US | disclosed |
| US-7223822-B2 | Multiple catalyst and reactor system for olefin polymerization and polymers produced therefrom | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2007-05-29 | — | — | US | disclosed |
| WO-2006100591-A1 | 4-PIPERAZINNYLTHIENO [2,3-D] PYRIMIDINE COMPOUNDS AS PLATELET AGGREGATION INHIBITORS | PHARMACIA & UPJOHN COMPANY LLC (US) | 2006-09-28 | — | — | WO | disclosed |
| EP-1473323-A1 | Polyethylene composition and process for producing same | Tosoh Corporation (JP) | 2004-11-03 | — | — | EP | disclosed |
| US-20040214953-A1 | Polyethylene composition and process for producing same | TOSOH CORPORATION | 2004-10-28 | — | — | US | disclosed |
| CN-1049899-C | Process for the preparation of a bridged metallocene compound as well as a catalyst component and a process for the polymerization of olefins | DSM NV (NL) | 2000-03-01 | — | — | CN | disclosed |
| CN-1128272-A | Process for the preparation of a bridged metallocene compound as well as a catalyst component and a process for the polymerization of olefins | DSM NV (NL) | 1996-08-07 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080176857-A1 | 4-Piperazinnylthieno[2,3-d]Pyrimidine Compounds as Platelet Aggregation Inhibitors | TBXA2R, P2RY4, PF4 | MAPT 4361/4885ALDH1A1 622/4885LMNA 2692/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.